• phone icon. 301-251-6638
    • Contact Us
    • Request a Quote
    • About Us
    • Distributors
    • Careers
    • 301-251-6638
    • Technical ResourcesTechnical
      Resources
      • Technical Resources
      • Citations & Testimonials
      • Order Support
      • FAQ
    • My Account
      My Account
      • Log In
      • Create Account
    • My Cart My Cart
      My Cart 1
    MENUMENU
    • Viral Packaging Services
      • AAV Packaging
      • Adenovirus Packaging
      • Lentivirus Packaging
      • Analytical Services
    • cGMP Services
      • cGMP AAV Production
      • cGMP Adenovirus Production
      • cGMP Lentivirus Production
      • cGMP Retrovirus Production
      • cGMP Custom Virus Production
      • Cell & Virus Banking
      • Aseptic Filling
      • Plasmid Manufacturing
      • cGMP QC Services
      • cGMP Process Development
      • IND/IMPD Services
    • Cloning Services
      • Molecular Cloning
      • Gene Synthesis & Mutagenesis
      • shRNA Cloning
      • CRISPR/Cas9 Cloning
    • Products
          • AAV Products
            • AAV Controls
            • AAV Biosensors
            • AAV Parkinson's Disease Tools
            • AAV Zika ORFs
          • Reference Standards
            • AAV Full Capsids
            • AAV Empty Capsids
          • Adenovirus Products
            • Adenovirus Controls
            • Adenovirus ORFs
            • Adenovirus miRNAs
            • Adenovirus Zika ORFs
          • Lentivirus Products
            • Lentivirus Controls
            • Lentivirus ORFs
          • Plasmid Products
            • Shuttle Vectors & Promoters
            • Plasmid ORFs
            • Plasmid miRNAs
            • Plasmid Zika ORFs
            • Plasmid shRNAs
          • GMP-ReadyTM/GMP Plasmids
            • AAV pHelper-Kan
          • SARS-CoV-2 – COVID-19 Vaccine Research Tools
            • Spike Pseudotyped Lentivirus
            • Adenovirus – SARS-CoV-2 Vaccine Research Tools
            • AAV – SARS-CoV-2 Vaccine Research Tools
    • Technologies
      • Upstream
      • Downstream
      • Producer Cell Lines
      • Facilities
    • Home
    • News & Events
    • Blog
    • Newsmakers: Vigene Biosciences Dr. Jeffrey Hung, Chief Commercial Officer, discusses Vigene’s new $20 million lab and strategic partnership with ASC Therapeutics

    Newsmakers: Vigene Biosciences Dr. Jeffrey Hung, Chief Commercial Officer, discusses Vigene’s new $20 million lab and strategic partnership with ASC Therapeutics

    Contract Pharma talks with Dr. Jeffrey Hung, CCO of Vigene, about the manufacturing challenges of cell and gene therapies.

    Contract Pharma talks with Dr. Jeffrey Hung, Chief Commercial Officer of Vigene Biosciences, about the strategic partnership, supporting manufacturing, and the future of cell and gene therapies. Please click here to view more.

    Viral Packaging Services

    • AAV Packaging
    • Adenovirus Packaging
    • Lentivirus Packaging
    • Analytical Services

    cGMP Services

    • cGMP AAV Production
    • cGMP Adenovirus Production
    • cGMP Lentivirus Production
    • cGMP Retrovirus Production
    • cGMP Custom Virus Production
    • Cell & Virus Banking
    • Aseptic Filling
    • Plasmid Manufacturing
    • cGMP QC Services
    • cGMP Process Development
    • IND/IMPD Services

    Cloning Services

    • Molecular Cloning
    • Gene Synthesis & Mutagenesis
    • shRNA Cloning
    • CRISPR/Cas9 Cloning

    Products

    • AAV Products
    • Adenovirus Products
    • Lentivirus Products
    • Plasmid Products

    Technologies

    • Upstream
    • Downstream
    • Producer Cell Lines
    • Facilities

    Resources

    • Technical Resources
    • Citations & Testimonials
    • FAQ

    About

    • Company
    • Newsroom
    • Leadership
    • Careers

    Contact

    • Contact Us
    • Request a Quote
    • How to Order
    • Distributors

    Address

    5 Research Court
    Rockville, MD 20850 USA

    Stay Connected

    Copyright 2021 Vigene Biosciences. All Rights Reserved. Terms and Conditions | Privacy Policy
      INC500-ACG-ARM-BETTER-TOGETHER-COVID19